Press Releases

Press Releases

May 10, 2021
Organogenesis Appoints Jon Giacomin to Board of Directors
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced
February 16, 2021
Organogenesis Appoints David C. Francisco as Chief Financial Officer
CANTON, Mass. , Feb. 16, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announces the
Displaying 1 - 10 of 12


Shareholder Tools